Related Experiment Video

Updated: Aug 16, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study

Ingmar Skoog1, Hans Lithell, Lennart Hansson

  • 1Institute of Clinical Neurosciences, Neuropsychiatric Epidemiology Unit, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden. Ingmar.Skoog@neuro.gu.se

American Journal of Hypertension
|August 20, 2005
PubMed

Insights

Elderly individuals with hypertension and mild cognitive impairment benefit from blood pressure-lowering therapy, which may reduce cognitive decline and stroke risk. This intervention shows promise for improving outcomes in this vulnerable population.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Neurology

Background:

  • The Study on COgnition and Prognosis in the Elderly (SCOPE) investigated the impact of blood pressure (BP)-lowering interventions on cognitive and cardiovascular outcomes.
  • Baseline cognitive function was assessed using the Mini Mental State Examination (MMSE) in elderly hypertensive patients.

Purpose of the Study:

  • To determine if baseline cognitive function influences cognitive and cardiovascular outcomes in the SCOPE trial.
  • To evaluate the efficacy of antihypertensive therapy in elderly patients with varying cognitive statuses.

Main Methods:

  • The SCOPE trial enrolled 4937 patients aged 70-89 with mild-to-moderate hypertension and MMSE scores >= 24.
  • Patients received either candesartan or placebo, with open-label antihypertensive therapy added as needed.
  • Cognitive function was categorized as low (MMSE 24-28) or high (MMSE 29-30).

Main Results:

  • Antihypertensive therapy effectively reduced BP in both low and high cognitive function groups.
  • Patients with low cognitive function at baseline had a higher incidence of dementia and cardiovascular events.
  • Candesartan treatment was associated with less cognitive decline (MMSE score) in patients with low cognitive function and reduced nonfatal stroke incidence in the total sample.

Conclusions:

  • Elderly hypertensive patients with slightly impaired cognitive function (MMSE 24-28) face elevated risks of dementia and cardiovascular events.
  • Effective antihypertensive therapy, such as candesartan, may mitigate cognitive decline and decrease stroke incidence in this population.
Abstract

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...